NCI Definition: A benign, borderline, or malignant neoplasm that affects the prostate gland. Representative examples include benign prostate phyllodes tumor, prostatic intraepithelial neoplasia, prostate carcinoma, and prostate sarcoma. 
Prostate neoplasms most frequently harbor alterations in TP53, TMPRSS2, ERG, PTEN, and AR .
TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, AR Amplification, and PTEN Loss are the most common alterations in prostate neoplasm .
There is 1 clinical trial for prostate neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains prostate neoplasm as an inclusion criterion, 1 is no phase specified (1 open).
Cryosurgery is the most common intervention in prostate neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.